期刊文献+

整合素α_5β_1和FAK在上皮卵巢肿瘤组织中的表达及意义 被引量:1

下载PDF
导出
摘要 目的研究整合素α5β1和黏着斑激酶(FAK)在卵巢上皮肿瘤组织中的表达及其与临床病理特征的关系。方法应用免疫组化方法检测49例卵巢上皮癌组织(观察组)和15例卵巢上皮良性肿瘤组织(对照组)中整合素α5β1和FAK的表达情况。结果观察组整合素α5β1和FAK的表达明显高于对照组(P<0.05);整合素α5β1阳性表达率与卵巢上皮癌组织的分化程度以及临床分期有关(P均<0.05),与患者年龄、肿瘤大小及组织学分型无关(P>0.05);FAK阳性表达率与卵巢上皮癌组织的临床分期有关(P<0.05),与患者年龄、分化程度、肿瘤大小及组织学分型无关(P>0.05);整合素α5β1、FAK在卵巢上皮癌组织中的表达呈正相关(r=0.490,P<0.01)。结论整合素α5β1、FAK在卵巢上皮癌组织中的表达具有相关性,与卵巢上皮癌的发生、侵袭和转移密切相关。
出处 《山东医药》 CAS 北大核心 2011年第29期89-90,共2页 Shandong Medical Journal
  • 相关文献

参考文献8

  • 1Cox BD, Natarajan M, Stettner MR, et al. New concepts regarding focal adhesion kinase promotion of cell migrationand proliferation [J]. J CellBiochem,2006,99(1) :35.
  • 2Gindberg MH, Partridge A, Shattil SJ. lntegrin regulation[ J]. Curt Opin Cell Biol,2005,17(5) :509-516.
  • 3韦德英,刘鸣,汤春生.整合素及纤粘连蛋白在调控卵巢癌细胞失巢凋亡过程中的作用[J].中国实用妇科与产科杂志,2007,23(12):926-928. 被引量:3
  • 4Banerjia A, Chakrabartt J, Mitra A, et al. Effect of curcumin on gelatinase A(MMP-2) activity in B16F10 melanoma cells[ J]. Cancer Letters ,2004,211 ( 2 ) :235-242.
  • 5Mitra A, Chakrabatt J, Chatterjee A. Binding of ct5 monoclonal antibody to cell surface ct5131 integrin modulates MMP-2 and MMP-7 acsivity in B16F10 melanoma cells [ J]. J Environ Pathol Toxicol Oncol,2003,22 (3) : 167-178.
  • 6查锡良.细胞粘附介导的信号分子——粘着斑激酶研究进展[J].生物化学与生物物理学报,1999,31(1):5-8. 被引量:8
  • 7Benlimame N, He Q, Jie S, et al. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic, transformation and invasion[ J]. J Cell Bio1,2005,171 (3) :505-516.
  • 8田芳,缪泽鸿,章雄文,丁健.整合蛋白信号转导研究进展[J].生命科学,2005,17(3):240-245. 被引量:5

二级参考文献29

  • 1陈洁,刘鸣,汤春生.整合素β1与卵巢癌侵袭性的相关研究[J].中国实用妇科与产科杂志,2005,21(4):240-241. 被引量:5
  • 2Zhu T,J Biol Chem,1998年,273卷,10682页
  • 3Shimaoka M, Takagi J, Springer T A. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct, 2002, 31:485-516.
  • 4Li R, Mitra N, Gratkowski H, et al. Activation of integrin αⅡbβ3 by modulation of transmembrane helix associations.Science, 2003, 300:795-798.
  • 5Vinogradova O, Vaynberg J, Kong X, et al. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc Natl Acad Sci USA, 2004, 101:4094-4099.
  • 6Barton S J, Travis M A, Askari J A, et al. Novel activating and inactivating mutations in the integrin β1 subunit A domain.Biochem J, 2004, 380:401-407.
  • 7Schwartz M A, Ginsberg M H. Networks and crosstalk:integrin signalling spreads. Nat Cell Biol, 2002, 4: E65-E68.
  • 8Schlaepfer D D, Mitra S K. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev, 2004, 14:92-101.
  • 9Parsons J T. Focal adhesion kinase: the first ten years. J Cell Sci, 2003, 116:1409-1416.
  • 10Schlaepfer D D, Mitra S K, Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta, 2004, 1692:77-102.

共引文献13

同被引文献14

  • 1Thomas TT,Ruscher KR,Mandavilli S. Ovarian steroid cell tumor,not otherwise specified,associated with congenital adrenal hyperplasia:rare tumors of an endocrine disease[J].{H}Journal of Pediatric Surgery,2013,(06):e23-e27.
  • 2Kim JH,Chung HH,Jeong MS. One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles[J].Int J Nanomedicine,2013,(08):2247-2257.
  • 3Nurliza Binti Md Nor,Kusumoto T,Inoue S. Three cases of struma ovarii underwent laparoscopic surgery with definite preoperative diagnosis[J].{H}ACTA MEDICA OKAYAMA,2013,(03):191-195.
  • 4Kumtepe Y,Halici Z,Sengul O. High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker[J].{H}European Journal of medical Reseasarch,2013,(18):18.
  • 5Hartwig M,Janiszewska H. Prevalence of the BRCA1 c.68_69delAG (BIC:185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country[J].Contemp Oncol (Pozn),2013,(01):34-37.
  • 6Di Leva G,Croce CM. The role of microRNAs in the tumorigenesis of ovarian cancer[J].Front Oncol,2013,(03):153.
  • 7夏兴焕,周保成.血清4项标志物联合检测对卵巢癌的诊断价值[J].检验医学与临床,2011,8(10):1189-1190. 被引量:4
  • 8陈锐,李庭芳,董志红,卢霞.绝经后卵巢肿瘤610例临床病理分析[J].中国妇幼保健,2011,26(34):5370-5372. 被引量:7
  • 9陈玉梅,王丽,钟丽红,刘瑶,余志惠,陈小娟.肿瘤标志物在卵巢癌早期诊断中的应用进展[J].当代医学,2012,18(20):12-13. 被引量:21
  • 10崔永伟,颜廷婷.CT、超声、CA125联合检测在卵巢癌诊断中的应用分析[J].中国性科学,2012,21(9):37-38. 被引量:10

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部